钠离子牛磺胆酸共转运多肽(sodium-taurocholate cotransporting polypeptide,NTCP)缺陷病是一种溶质载体家族10成员1(solute carrier family 10 member 1,SLC10A1)双等位基因突变引起的胆汁酸代谢障碍性疾病,分布具有区域和种族差异,其...钠离子牛磺胆酸共转运多肽(sodium-taurocholate cotransporting polypeptide,NTCP)缺陷病是一种溶质载体家族10成员1(solute carrier family 10 member 1,SLC10A1)双等位基因突变引起的胆汁酸代谢障碍性疾病,分布具有区域和种族差异,其中SLC10A1 c.800C>T(p.Ser267Phe)是我国的高频突变。NTCP缺陷病患儿主要表现为病理性黄疸,少部分有生长、运动和神经系统发育迟缓的表现,成年患者临床症状和体征不明显,生化检查提示血清总胆汁酸水平升高、部分伴有转氨酶和25-羟维生素D3水平降低。NTCP缺陷病性高胆汁酸血症需与乙型肝炎病毒感染、丁型肝炎病毒感染、自身免疫性肝炎及妊娠期肝内胆汁淤积症等鉴别,妊娠合并NTCP缺陷病性高胆汁酸血症对母胎的影响迄今少有相关报道。综述NTCP缺陷病的分子遗传机制、临床表现、实验室检查、诊断、治疗及其对母胎的影响,为该病患者的明确诊断和正确干预提供依据。展开更多
BACKGROUND Sodium taurocholate cotransport polypeptide(NTCP)deficiency disease is a genetic metabolic disorder due to mutations in the SLC10A1 gene and impaired bile acid salt uptake by the basolateral membrane transp...BACKGROUND Sodium taurocholate cotransport polypeptide(NTCP)deficiency disease is a genetic metabolic disorder due to mutations in the SLC10A1 gene and impaired bile acid salt uptake by the basolateral membrane transport protein NTCP in hepatocytes.A variety of clinical manifestations and genetic mutation loci have been reported for this disease.However,specific therapeutic measures are lacking,and the long-term effects are unknown.CASE SUMMARY An infant with elevated bile acids and behavioral neurodevelopmental delay failed to respond to bile acid-lowering therapy.Genetic testing for metabolic liver disease revealed that the child had NTCP deficiency due to the SLC10A1 mutation:c.422dupA(p.Y141X),which is a novel mutation site.The current followup revealed a gradual decrease in bile acid levels after 1 year of age,but the child still had behavioral neurodevelopmental delays.CONCLUSION The clinical manifestations,genetic characteristics,treatment and long-term prognosis due to NTCP deficiency remain poorly defined and need to be further confirmed by more studies and reports.展开更多
文摘钠离子牛磺胆酸共转运多肽(sodium-taurocholate cotransporting polypeptide,NTCP)缺陷病是一种溶质载体家族10成员1(solute carrier family 10 member 1,SLC10A1)双等位基因突变引起的胆汁酸代谢障碍性疾病,分布具有区域和种族差异,其中SLC10A1 c.800C>T(p.Ser267Phe)是我国的高频突变。NTCP缺陷病患儿主要表现为病理性黄疸,少部分有生长、运动和神经系统发育迟缓的表现,成年患者临床症状和体征不明显,生化检查提示血清总胆汁酸水平升高、部分伴有转氨酶和25-羟维生素D3水平降低。NTCP缺陷病性高胆汁酸血症需与乙型肝炎病毒感染、丁型肝炎病毒感染、自身免疫性肝炎及妊娠期肝内胆汁淤积症等鉴别,妊娠合并NTCP缺陷病性高胆汁酸血症对母胎的影响迄今少有相关报道。综述NTCP缺陷病的分子遗传机制、临床表现、实验室检查、诊断、治疗及其对母胎的影响,为该病患者的明确诊断和正确干预提供依据。
基金Yunnan Science Foundation Project,No.2019-81960102.
文摘BACKGROUND Sodium taurocholate cotransport polypeptide(NTCP)deficiency disease is a genetic metabolic disorder due to mutations in the SLC10A1 gene and impaired bile acid salt uptake by the basolateral membrane transport protein NTCP in hepatocytes.A variety of clinical manifestations and genetic mutation loci have been reported for this disease.However,specific therapeutic measures are lacking,and the long-term effects are unknown.CASE SUMMARY An infant with elevated bile acids and behavioral neurodevelopmental delay failed to respond to bile acid-lowering therapy.Genetic testing for metabolic liver disease revealed that the child had NTCP deficiency due to the SLC10A1 mutation:c.422dupA(p.Y141X),which is a novel mutation site.The current followup revealed a gradual decrease in bile acid levels after 1 year of age,but the child still had behavioral neurodevelopmental delays.CONCLUSION The clinical manifestations,genetic characteristics,treatment and long-term prognosis due to NTCP deficiency remain poorly defined and need to be further confirmed by more studies and reports.